Gravemann U et al., 2018-02-27: Process-validation study showing that the temperature of plasma during methylene blue/light treatment changes both virus inactivation (worse at 5 degrees C, because the MB tablet dissolves poorly) and plasma quality.
Inactivation of suid herpesvirus, bovine viral diarrhoea virus and vesicular stomatitis virus was significantly lower at 5 ± 2°C than at higher temperatures.
Abstract
Gravemann U et al., 2018-02-27: Process-validation study showing that the temperature of plasma during methylene blue/light treatment changes both virus inactivation (worse at 5 degrees C, because the MB tablet dissolves poorly) and plasma quality. Study type: in vitro process-validation study (three viruses, coagulation factors, clotting times); no human subjects. Country: Germany. Temperatures compared: 5+/-2, 22+/-2 and 30+/-2 degrees C. Shows the method is sensitive to operating conditions , a real-world robustness caveat. Funding/COI not in retrieved abstract record; Macopharma co-authors. Study type: lab.
